Pfm Health Sciences, LP Acadia Pharmaceuticals Inc Call Options Transaction History

Pfm Health Sciences, LP

  • $1.95 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$15.78 - $24.77 $9.5 Million - $14.9 Million
-602,100 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$19.4 - $27.42 $6.44 Million - $9.11 Million
332,100 Added 123.0%
602,100 $14.7 Million
Q4 2020

Feb 16, 2021
BUY
$41.04 - $56.79 $11.1 Million - $15.3 Million
270,000 New
270,000 $14.4 Million

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email